Roche returns for a further Matterhorn ascent
Swiss healthcare firm Roche returned to its native market on Wednesday with a Sfr1.5bn ($1.49bn) triple tranche trade in the largest ‘Matterhorn’ — a deal of Sfr1bn or more — since its last outing in 2012.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: